Search - tctmd.com

Displaying 341 - 360 of 904

Sort: Relevancy | Date

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

Presenter: Mahmoud Barbarawi

October 14, 2020

Presentation TCT 2020

TCT 378: Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single Center Large Volume PCI Registry

Presenter: Johny Nicolas

October 14, 2020

Presentation TCT 2020

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2020

TCT 383: Impact of Coronary Lesion Severity on Long Term Cardiac Outcomes in Renal Transplant Candidates

Presenter: Maulin Shah

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 382: Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support

Presenter: Nausharwan Butt

October 14, 2020

Presentation TCT 2020

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

Presenter: Charan Yerasi

October 14, 2020

Presentation TCT 2020

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

Presenter: Sandeep Basavarajaiah

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Presentation TCT 2020

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

Presenter: A D S P K Athukorala

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

Presenter: Dimitri Karmpaliotis

October 14, 2020

Presentation TCT 2020

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Adrian Wlodarczak

October 14, 2020

Presentation TCT 2020

TCT 263: A Novel Risk Score to Predict One-year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP PCI)

Presenter: Sorin Brener

October 14, 2020

Presentation TCT 2020

TCT 256: Computational Modelling to Assess Efficacy of Drug Coated Balloon Therapy

Presenter: Karthic Anbalakan

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

Presentation TCT 2020

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

Presenter: Takeshi Nishi

October 14, 2020

Advertisement

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

TCT 378: Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single Center Large Volume PCI Registry

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

TCT 383: Impact of Coronary Lesion Severity on Long Term Cardiac Outcomes in Renal Transplant Candidates

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 382: Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

TCT 263: A Novel Risk Score to Predict One-year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP PCI)

TCT 256: Computational Modelling to Assess Efficacy of Drug Coated Balloon Therapy

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content